Азацитидин Фармасайънс

Азацитидин Фармасайънс is a prescription medication used for certain blood disorders. It belongs to the class of antineoplastic agents and is administered subcutaneously. This product is manufactured by Pharmascience International Ltd and is available in the EU market.

Азацитидин Фармасайънс is used to treat myelodysplastic syndromes, a group of blood disorders that can lead to leukemia. It is also prescribed for chronic myelomonocytic leukemia and acute myeloid leukemia in specific patient groups. This medication helps regulate blood cell production and may slow disease progression.

Азацитидин Фармасайънс works by altering the growth of abnormal cells in the bone marrow. Patients may experience improved blood cell counts over time. Some individuals report reduced fatigue and improved overall well-being during treatment. Effects vary and should be monitored by a healthcare professional.

This medication should be handled with care, as it may cause harm to unborn babies. Pregnant individuals or those planning pregnancy should avoid exposure. It is important to follow safe handling practices, including proper disposal of needles and syringes. Always store the medication as directed by a healthcare provider.

Азацитидин Фармасайънс may interact with other medications, including those that affect the liver or blood cell production. Alcohol and certain supplements could influence its effects. Patients should inform their doctor about all medications and supplements they are taking. Regular monitoring may be required to manage potential interactions.